Drug Type Fusion protein |
Synonyms |
Target |
Mechanism IFNA8 modulators(interferon alpha 8 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Preclinical | TW | 30 Nov 2022 | |
Colorectal Cancer | Preclinical | TW | 30 Nov 2022 | |
Hepatitis B | Preclinical | TW | 30 Nov 2022 | |
Hepatitis C | Preclinical | TW | 30 Nov 2022 | |
Melanoma | Preclinical | TW | 30 Nov 2022 | |
Ovarian Cancer | Preclinical | TW | 30 Nov 2022 | |
Prostatic Cancer | Preclinical | TW | 30 Nov 2022 |